Trial Profile
A Phase II study of Paclitaxel, and Vinorelbine (Pacl-Vin) in Hormone-refractory metastatic prostate cancer: Double Tubulin Targeting
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Vinorelbine
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms Pacl-vin
- Sponsors Bristol-Myers Squibb; Pierre Fabre
- 21 Jan 2009 New trial record.